Works matching DE "DRUG eruptions"

Results: 1205

Fatal toxic epidermal necrolysis associated with an immune checkpoint inhibitor.

Published in:

Journal of Cutaneous Immunology & Allergy, 2025, p. 1, doi. 10.3389/jcia.2025.14584

By:

Seki, Chiaki;
Koike, Yuta;
Higuchi, Misato;
Ikenaga, Eri;
Waseda, Tomoka;
Ichiki, Mio;
Ehara, Daisuke;
Takenaka, Motoi;
Kusano, Keiko;
Sonoda, Yuuki;
Murota, Hiroyuki

Publication type:

Article

Positive Osimertinib Patch Test in a Bullous Lichenoid Drug Reaction.

Published in:

Contact Dermatitis (01051873), 2025, v. 93, n. 2, p. 165, doi. 10.1111/cod.14810

By:

Marcombes, Clarisse;
Bel Hareth, Kamar;
Mazoyer, Héloïse;
Solinas, Sabina;
Ingen‐Housz‐Oro, Saskia;
Assier, Haudrey

Publication type:

Article

Skin Reactions as a Prognostic Factor in Immunotherapy of Non-Small Cell Lung Cancer.

Published in:

International Medical Journal, 2025, v. 32, n. 2, p. 97

By:

Kolasa, Eliza;
Paluch, Alicja;
Koźlicka, Aleksandra;
Szklener, Katarzyna

Publication type:

Article

Extensive T-Cell Cutaneous Lymphoid Hyperplasia—A Challenging Case Managed Successfully with Methotrexate.

Published in:

2025

By:

Jagruti, Gunda;
Gopal, K. V. T.;
Karri, Sudhir B.;
Tarra, Reshma

Publication type:

Case Study

New onset MDA‐5 positive dermatomyositis and massive perivillous fibrin deposition in third trimester of pregnancy: A case report.

Published in:

Journal of Obstetrics & Gynaecology Research, 2023, v. 49, n. 6, p. 1620, doi. 10.1111/jog.15625

By:

Krones, Charlotte;
Vu, Mi;
Popp, Benjamin;
Scardamaglia, Laura

Publication type:

Article

Ferric derisomaltose for the treatment of iron deficiency anemia with postpartum hemorrhage: Results of a single‐arm, open‐label, phase 3 study in Japan.

Published in:

Journal of Obstetrics & Gynaecology Research, 2023, v. 49, n. 3, p. 946, doi. 10.1111/jog.15546

By:

Sugimura, Motoi;
Ohtani, Yasuyoshi;
Tamai, Soichiro;
Kishimoto, Umi;
Ito, Naoki

Publication type:

Article

Associations between endometriosis and allergy‐related diseases as well as different specific immunoglobulin E allergy: A cross‐sectional study.

Published in:

Journal of Obstetrics & Gynaecology Research, 2023, v. 49, n. 2, p. 665, doi. 10.1111/jog.15506

By:

Chen, Shuozhen;
Liu, Juan

Publication type:

Article

Oxcarbazepine-induced serious skin reaction.

Published in:

Brown University Psychopharmacology Update, 2014, v. 25, n. 11, p. 2

By:

Lam, Y. W. Francis

Publication type:

Article

Persistent localized rash after trauma. Infection or iatrogenic disease?

Published in:

2001

By:

Keith, M P;
Spooner, K

Publication type:

journal article

Two different lesions, same reason. Fixed drug eruption.

Published in:

2000

By:

Mishriki, Y Y

Publication type:

journal article

Juvenile primary Sjogren's syndrome with cutaneous involvement.

Published in:

Clinical Rheumatology, 2021, v. 40, n. 9, p. 3687, doi. 10.1007/s10067-021-05656-0

By:

He, Songwei;
Zhen, Xiaofang;
Hu, Yan

Publication type:

Article

Survival Time among Young and Old Breast Cancer Patients in Relation to Circulating Blood-Based Biomarkers, Acute Radiation Skin Reactions, and Tumour Recurrence.

Published in:

Oncology, 2021, v. 99, n. 11, p. 740, doi. 10.1159/000518184

By:

Laytragoon Lewin, Nongnit;
Oliva, Delmy;
Nilsson, Mats;
Andersson, Bengt-Åke;
Löfgren, Sture;
Lewin, Freddi

Publication type:

Article

OP089 INCIDENCE AND CHARACTERISTICS OF MEDICAL ADHESIVE-RELATED SKIN INJURIES IN PATIENTS FOLLOWING SPINAL SURGERY.

Published in:

Journal of Wound Management, 2023, v. 24, n. 2, p. 436

By:

Tae Yeong Yang;
Jung Eun Park;
Jun Bum Kim;
Na Hyun Lee

Publication type:

Article

OP014 A CASE OF AN EMBOLIA CUTIS MEDICAMENTOSA (NICOLAU SYNDROME) CAUSED BY DICLOFENAC INJECTIONS.

Published in:

Journal of Wound Management, 2023, v. 24, n. 2, p. 388

By:

Salmivuori, Mari;
Tolkki, Lauri;
Jeskanen, Leila

Publication type:

Article

Bullous drug eruption with low dose methotrexate.

Published in:

Northern Clinics of Istanbul, 2021, v. 8, n. 6, p. 617, doi. 10.14744/nci.2020.83798

By:

Inel, Tuba Yuce

Publication type:

Article

Therapeutic and prophylactic effects of strontium on radiotherapy-induced skin toxicity in rats.

Published in:

Turkish Archives of Dermatology & Venerology / Turkderm, 2017, v. 51, n. 4, p. 109, doi. 10.4274/turkderm.74150

By:

Yücel, Birsen;
Hayta, Sibel Berksoy;
Göze, Ömer Fahrettin;
Erdiş, Eda;
Bahar, Seher;
Celasun, Mustafa Gürol;
Kaçan, Turgut;
Akyol, Melih

Publication type:

Article

A toxicity and hazard assessment of fourteen pharmaceuticals to Xenopus laevis larvae.

Published in:

Ecotoxicology, 2006, v. 15, n. 8, p. 647, doi. 10.1007/s10646-006-0102-4

By:

Richards, Sean M.;
Cole, Shaun E.

Publication type:

Article

Cutaneous Adverse Drug Reactions Associated with SGLT2 Inhibitors.

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 1, p. 188, doi. 10.3390/jcm14010188

By:

Mederle, Alexandra Laura;
Dumitrescu, Patrick;
Borza, Claudia;
Kundnani, Nilima Rajpal

Publication type:

Article

Nimesulide-Induced Fixed Drug Eruption Followed by Etoricoxib-Induced Fixed Drug Eruption: An Unusual Case Report and Review of the Literature.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 6, p. 1583, doi. 10.3390/jcm13061583

By:

Makris, Michael;
Papapostolou, Niki;
Koumprentziotis, Ioannis-Alexios;
Pappa, Georgia;
Katoulis, Alexander C.

Publication type:

Article

Acute Localized Exanthematous Pustulosis (ALEP) Caused by Topical Application of Minoxidil.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 831, doi. 10.3390/jcm12030831

By:

Makris, Michael;
Kanelleas, Antonios;
Papapostolou, Niki;
Pisimisi, Maria;
Katoulis, Alexander C.

Publication type:

Article

Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients.

Published in:

2022

By:

Vallejo-Yagüe, Enriqueta;
Martinez-De la Torre, Adrian;
Mohamad, Omar S.;
Sabu, Shweta;
Burden, Andrea M.

Publication type:

Case Study

Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 22, p. 5344, doi. 10.3390/jcm10225344

By:

Bellinato, Francesco;
Maurelli, Martina;
Gisondi, Paolo;
Girolomoni, Giampiero

Publication type:

Article

A Network Analysis of Drug Combinations Associated with Acute Generalized Exanthematous Pustulosis (AGEP).

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 19, p. 4486, doi. 10.3390/jcm10194486

By:

Martinez-De la Torre, Adrian;
van Weenen, Eva;
Kraus, Mathias;
Weiler, Stefan;
Feuerriegel, Stefan;
Burden, Andrea M.

Publication type:

Article

The Clinical and Histopathological Features of Cutaneous Immune-Related Adverse Events and Their Outcomes.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 4, p. 728, doi. 10.3390/jcm10040728

By:

Hashimoto, Hiroki;
Ito, Takamichi;
Ichiki, Toshio;
Yamada, Yuichi;
Oda, Yoshinao;
Furue, Masutaka;
Lopci, Egesta

Publication type:

Article

A Narrative Review on Evaluation of Causal Drug in Cutaneous Drug Eruptions: Challenges, Current State, and the Path Ahead.

Published in:

International Journal of Advanced Medical & Health Research, 2024, v. 11, n. 2, p. 80, doi. 10.4103/ijamr.ijamr_295_24

By:

Ramassamy, Sivaranjini

Publication type:

Article

Dermatomyositis with Eosinophils.

Published in:

Dermatopathology, 2023, v. 10, n. 4, p. 310, doi. 10.3390/dermatopathology10040039

By:

Sanchez, Isabella I.;
Herrera, Henry O.;
Elsensohn, Ashley;
Lee, Bonnie A.;
Kraus, Christina N.

Publication type:

Article

Histopathologic Features of Maculopapular Drug Eruption.

Published in:

Dermatopathology, 2022, v. 9, n. 2, p. 111, doi. 10.3390/dermatopathology9020014

By:

Ernst, Madison;
Giubellino, Alessio

Publication type:

Article

Targeting RAF1 gene fusions with MEK inhibition in metastatic melanoma.

Published in:

Oncologist, 2025, v. 30, n. 3, p. 1, doi. 10.1093/oncolo/oyae297

By:

Khaddour, Karam;
Haq, Rizwan;
Buchbinder, Elizabeth I;
Liu, David;
Manos, Michael P;
Ott, Patrick A;
Hodi, F Stephen;
Insco, Megan L

Publication type:

Article

Ribociclib-Induced Cutaneous Adverse Events in Metastatic HR+/HER2− Breast Cancer: Incidence, Multidisciplinary Management, and Prognostic Implication.

Published in:

Oncologist, 2024, v. 29, n. 6, p. 484, doi. 10.1093/oncolo/oyae004

By:

Borroni, Riccardo Giovanni;
Bartolini, Michela;
Gaudio, Mariangela;
Jacobs, Flavia;
Benvenuti, Chiara;
Gerosa, Riccardo;
Tiberio, Paola;
Manara, Sofia Ada Assunta Maria;
Solferino, Alessandra;
Santoro, Armando;
Sanctis, Rita De

Publication type:

Article

In Reply.

Published in:

2022

By:

Lacouture, Mario E;
Patel, Anisha B;
Rosenberg, Jonathan E;
O'Donnell, Peter H

Publication type:

Letter to the Editor

Regarding "Management of Dermatologic Events Associated with the Nectin-4–directed Antibody-Drug Conjugate Enfortumab Vedotin".

Published in:

2022

By:

Ingen-Housz-Oro, Saskia;
Thibault, Constance;
Sohier, Pierre;
Dupin, Nicolas

Publication type:

Letter to the Editor

In Reply.

Published in:

2022

By:

Lacouture, Mario E;
Patel, Anisha B;
Rosenberg, Jonathan E;
O'Donnell, Peter H

Publication type:

Letter to the Editor

Regarding "Management of Dermatologic Events Associated with the Nectin-4–directed Antibody-Drug Conjugate Enfortumab Vedotin".

Published in:

2022

By:

Ingen-Housz-Oro, Saskia;
Thibault, Constance;
Sohier, Pierre;
Dupin, Nicolas

Publication type:

Letter to the Editor

Management of Dermatologic Events Associated With the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin.

Published in:

Oncologist, 2022, v. 27, n. 3, p. e223, doi. 10.1093/oncolo/oyac001

By:

Lacouture, Mario E;
Patel, Anisha B;
Rosenberg, Jonathan E;
O'Donnell, Peter H

Publication type:

Article

Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines.

Published in:

Oncologist, 2021, v. 26, n. 2, p. e316, doi. 10.1002/onco.13552

By:

Lacouture, Mario E.;
Sibaud, Vincent;
Anadkat, Milan J.;
Kaffenberger, Benjamin;
Leventhal, Jonathan;
Guindon, Kathleen;
Abou‐Alfa, Ghassan

Publication type:

Article

A Phase Ib Study of Single‐Agent Idelalisib Followed by Idelalisib in Combination with Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.

Published in:

Oncologist, 2020, v. 25, n. 11, p. e1604, doi. 10.1634/theoncologist.2020-0321

By:

Borazanci, Erkut;
Pishvaian, Michael J.;
Nemunaitis, John;
Weekes, Colin;
Huang, Julie;
Rajakumaraswamy, Nishanthan

Publication type:

Article

Nivolumab in Advanced Hepatocellular Carcinoma: Safety Profile and Select Treatment‐Related Adverse Events From the CheckMate 040 Study.

Published in:

Oncologist, 2020, v. 25, n. 10, p. e1532, doi. 10.1634/theoncologist.2019-0591

By:

Julien, Karen;
Leung, Hiu Tung;
Fuertes, Carmen;
Mori, Megumi;
Wang, Miao‐Jen;
Teo, Jocelyn;
Weiss, Lisa;
Hamilton, Sara;
DiFebo, Holly;
Noh, Yoon Jin;
Galway, Aralee;
Koh, Jane;
Brutcher, Edith;
Zhao, Huanyu;
Shen, Yun;
Tschaika, Marina;
To, Yue‐Yun

Publication type:

Article

Hypertrophic Lichen Planus with Histological Features of Squamous Cell Carcinoma Associated with Immune Checkpoint Blockade Therapy.

Published in:

Oncologist, 2020, v. 25, n. 5, p. 366, doi. 10.1634/theoncologist.2019-0796

By:

Ameri, Amir H.;
Foreman, Ruth K.;
Vedak, Priyanka;
Chen, Steven;
Miller, David M.;
Demehri, Shadmehr

Publication type:

Article

A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor‐Induced Skin Toxicities.

Published in:

Oncologist, 2020, v. 25, n. 1, p. e186, doi. 10.1634/theoncologist.2019-0221

By:

Kim, Young Saing;
Ji, Jun Ho;
Oh, Sung Yong;
Lee, Suee;
Huh, Seok Jae;
Lee, Ji Hyun;
Song, Ki‐Hoon;
Son, Choon Hee;
Roh, Mee Sook;
Lee, Gyeong Won;
Lee, Jeeyun;
Kim, Seung Tae;
Kim, Chan Kyu;
Jang, Joung Soon;
Hwang, In Gyu;
Ahn, Hee Kyung;
Park, Lee Chun;
Oh, So Yeon;
Kim, Seong‐Geun;
Lee, Sang‐Cheol

Publication type:

Article

Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System.

Published in:

Oncologist, 2019, v. 24, n. 11, p. e1228, doi. 10.1634/theoncologist.2019-0250

By:

Raschi, Emanuel;
Antonazzo, Ippazio Cosimo;
La Placa, Michelangelo;
Ardizzoni, Andrea;
Poluzzi, Elisabetta;
De Ponti, Fabrizio

Publication type:

Article

Cutaneous Toxicity After Chemoradiotherapy and PD‐L1 Inhibition in Two Patients with Esophageal Adenocarcinoma: More than Meets the Eye.

Published in:

Oncologist, 2019, v. 24, n. 4, p. e149, doi. 10.1634/theoncologist.2018-0674

By:

Ende, Tom;
Menting, Stef P.;
Ambarus, Carmen A.;
Oijen, Martijn G.H.;
Laarhoven, Hanneke W.M.

Publication type:

Article

Strategies for Recognizing and Managing Immune‐Mediated Adverse Events in the Treatment of Hodgkin Lymphoma with Checkpoint Inhibitors.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 86, doi. 10.1634/theoncologist.2018-0045

By:

Vardhana, Santosha;
Cicero, Kara;
Velez, Moises J.;
Moskowitz, Craig H.

Publication type:

Article

Cutaneous diseases developed following BNT162b2 and CoronaVac vaccines.

Published in:

Journal of Experimental & Clinical Medicine / Deneysel ve Klinik Tip Dergisi, 2024, v. 41, n. 1, p. 65, doi. 10.52142/omujecm.41.1.11

By:

YEGİN BENER, Fidan

Publication type:

Article

A Cross Sectional Study of Cutaneous Adverse Drug Reactions in a Tertiary Health Centre.

Published in:

Malaysian Journal of Medicine & Health Sciences, 2024, v. 20, p. 39, doi. 10.47836/mjmhs.20.s13.9

By:

Anannya S.;
Wahab, Afthab Jameela;
Sharada R. G.

Publication type:

Article

A case of erythema multiforme drug eruption associated with erythrodermic psoriasis induced by sofosbuvir and daclatasvir.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2017, v. 42, n. 1, p. 108, doi. 10.1111/jcpt.12467

By:

Wang, Y.;
Liu, P.

Publication type:

Article

Case report: Apalutamide-induced severe lethal cutaneous adverse effects in China.

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1291564

By:

Qi Wang;
Huali Cao;
Xuetong Zhang;
Huifeng Wu;
Zhuangli Tang

Publication type:

Article

New insight into the causal relationship between Graves’ disease liability and drug eruption: a Mendelian randomization study.

Published in:

Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1267814

By:

Dide Wu;
Boyuan Liu;
Wei Xian;
Yuxin Yang;
Jinjian Li;
Shubin Hong;
Yanbing Li;
Haipeng Xiao

Publication type:

Article

Levetiracetam-Induced Drug Reaction: Violaceous Discrete Maculopapular Rash: A Case Report.

Published in:

Apollo Medicine, 2023, v. 20, n. 1, p. 83, doi. 10.4103/am.am_142_22

By:

Kour, Arvinpreet;
Singh, Ajaydeep

Publication type:

Article

Impact of Coronavirus Disease 2019 in Dermatology.

Published in:

Apollo Medicine, 2023, v. 20, n. 1, p. 38, doi. 10.4103/am.am_146_22

By:

Kumari, Jyoti;
Gorai, Surajit;
Das, Kinnor;
Lahiri, Koushik

Publication type:

Article

Multiple eruptive dermatofibromas aggravated by mycophenolate mofetil and pirfenidone in a patient with systemic sclerosis.

Published in:

2020

By:

Wang, Rui;
Li, Guangtao;
Nong, Lin;
Wang, Mingyue

Publication type:

Case Study